Recall Register

Food, drugs, devices › Ra Medical Systems Inc

Device recall: PHAROS Excimer Laser, Model No. EX-308 UVB phototherapy for the treatment of psoriasis, vitiligo, atopic dermatitis and

FDA enforcement event 68706 · Class II · initiated 30 Jun 2014 · status Terminated · terminated 9 Sep 2014

DeviceVoluntary: Firm initiated1 product recordCarlsbad, CA

Ra Medical Systems Inc (Carlsbad, CA) initiated this device recall on 30 Jun 2014; FDA lists 1 product record under event 68706, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,176 device enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 9 Sep 2014. Initiation: voluntary: firm initiated. Ra Medical Systems Inc has 7 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Ra Medical Systems Inc, Carlsbad, CA.

Reason for recall

"RA Medical Systems is recalling the PHAROS EX-308 Excimer Laser because there is a possibility that the laser may calibrate with the iris closed."

Distribution

"Worldwide Distribution - USA (Nationwide) and Internationally to: Korea, Kuwait, and Saudi Arabia."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2123-2014PHAROS Excimer Laser, Model No. EX-308 UVB phototherapy for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma435 unitsClass IITerminated6 Aug 2014

Context

91%of 2014 device events are Class II1,176 events that year
1product record in this eventfirm median: 1
7events on this register for the firm

Other enforcement events for Ra Medical Systems Inc

InitiatedProduct (first record)TypeClassRecords
16 Oct 2020DABRA Laser (RA-308 Excimer Laser) Intended Use: For use in ablating a channel in occlusive peripheral vascular disease.DeviceClass II1
24 Jul 2020DABRA RA-308 Excimer Laser, SN: ******* - Product Usage: The device is intended for use in ablating a channel in occlusiDeviceClass II1
23 Jan 2020DABRA Laser (RA-308 Excimer Laser). The DABRA Laser and DABRA Catheter is an excimer laser ultraviolet light source and DeviceClass II1
19 Sep 2019Ra Medical Systems DABRA Catheter 5F (1.5mm), REF: 1222-5000-01, LOT: 18-090400-094, USE BY: 2019-09-24, MFR DATE: 2018-DeviceClass II1
23 Aug 2019Pharos Excimer Laser, Model: EX-308 - Product Usage: The Pharos EX-308 Excimer Laser System is designed to treat the skiDeviceClass II1
15 Feb 2018The DABRA Laser (model RA-308) is designed to provide ultraviolet laser energy endovascularly through a catheter to occlDeviceClass II1

All 7 events for Ra Medical Systems Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "RA Medical Systems is recalling the PHAROS EX-308 Excimer Laser because there is a possibility that the laser may calibrate with the iris closed."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA (Nationwide) and Internationally to: Korea, Kuwait, and Saudi Arabia."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 9 Sep 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.